Bajaj Healthcare forges CDMO agreement with UK/EU clients for API supply
Bajaj Healthcare Ltd., a prominent figure in the pharmaceutical industry specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Formulations, has announced a ... Read More
Lupin Limited announces satisfactory FDA inspection results for Mandideep facility
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for ... Read More
Cambrex announces $425m acquisition of American CDMO Halo Pharma
Cambrex Corporation, a leading manufacturer of small molecules and generic Active Pharmaceutical Ingredients (APIs), has announced a strategic acquisition of Halo Pharma for $425 million. ... Read More